[Form 3] SUPERNUS PHARMACEUTICALS, INC. Initial Statement of Beneficial Ownership
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Supernus Pharmaceuticals SVP William Todd Horich filed an initial ownership report showing his equity holdings in the company. The filing lists multiple employee stock options on common stock with exercise prices such as $39.4000 and $27.9400, expiring between 2028 and 2036, as well as restricted stock units and performance share units that vest in four equal annual installments beginning on dates including February 23, 2024, February 22, 2025, February 19, 2026 and February 18, 2027. He also holds 4,832 shares of common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
16 transactions reported
Mixed
16 txns
Insider
Horich William Todd
Role
SVP, Commercial Operations
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Performance Share Unit | -- | -- | -- |
| holding | Performance Share Unit | -- | -- | -- |
| holding | Performance Share Unit | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 13,000 shares (Direct);
Restricted Stock Unit — 6,250 shares (Direct);
Performance Share Unit — 3,750 shares (Direct);
Common Stock — 4,832 shares (Direct)
Footnotes (1)
- The option vests in four equal annual installments beginning on February 14, 2019. The option vests in four equal annual installments beginning on February 22, 2020. The option vests in four equal annual installments beginning on February 19, 2022. The option vests in four equal annual installments beginning on February 22, 2023. The option vests in four equal annual installments beginning on February 23, 2024. The option vests in four equal annual installments beginning on February 22, 2025. The option vests in four equal annual installments beginning on February 19, 2026. The option vests in four equal annual installments beginning on February 18, 2027. These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027. On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.
